91 related articles for article (PubMed ID: 23350468)
1. [Oral chemotherapy for advanced breast cancer].
Nakagawa M; Morimoto M; Tangoku A
Nihon Rinsho; 2012 Sep; 70 Suppl 7():587-91. PubMed ID: 23350468
[No Abstract] [Full Text] [Related]
2. Oral fluoropyrimidines in colorectal cancer.
Van Cutsem E; Peeters M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):91-5. PubMed ID: 11049039
[No Abstract] [Full Text] [Related]
3. [Intravenous continuous infusion of fluorouracil for treatment of metastatic colorectal cancer].
Hosokawa A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():352-5. PubMed ID: 14574911
[No Abstract] [Full Text] [Related]
4. Oral treatment for gastric cancer: new choices, better choices?
Cascinu S
Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
[No Abstract] [Full Text] [Related]
5. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
Kato K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
[No Abstract] [Full Text] [Related]
6. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
Ilson D
J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
[No Abstract] [Full Text] [Related]
7. Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
Benson AB
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-17-21. PubMed ID: 23570133
[No Abstract] [Full Text] [Related]
8. Oral fluoropyrimidine treatment of colorectal cancer.
Eng C; Kindler HL; Schilsky RL
Clin Colorectal Cancer; 2001 Aug; 1(2):95-103. PubMed ID: 12445367
[TBL] [Abstract][Full Text] [Related]
9. [S-1 for treatment of breast cancers].
Saeki T; Takashima S
Nihon Rinsho; 2000 Apr; 58 Suppl():284-91. PubMed ID: 11026008
[No Abstract] [Full Text] [Related]
10. [Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer].
Okamura R; Kato T; Sata R
Nihon Rinsho; 2012 Sep; 70 Suppl 7():592-6. PubMed ID: 23350469
[No Abstract] [Full Text] [Related]
11. [Clinical benefit of S-1 in metastatic breast cancer].
Saeki T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Murakami S; Yamamoto Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1147-9. PubMed ID: 17637560
[TBL] [Abstract][Full Text] [Related]
13. Oral fluoropyrimidines in cancer treatment.
Lewis NL; Meropol NJ
Cancer Invest; 2000; 18(8):747-60. PubMed ID: 11107445
[No Abstract] [Full Text] [Related]
14. [Concentration of FT and CDHP and 5-FU in the ascites fluid of patient with peritoneal carcinomatosis after new anti-cancer drug TS-1 oral administration].
Iizuka R; Takahashi S; Kakihara N; Matsumura H; Takenaka A
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1251-3. PubMed ID: 12146009
[No Abstract] [Full Text] [Related]
15. [Gastric cancer with multiple liver metastases, which responded significantly to oral administration of TS-1 following intravenous FMP therapy under hospitalization].
Tasaka K; Okada Y; Tomofuji Y; Chinzei T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1631-5. PubMed ID: 12355951
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():144-9. PubMed ID: 16897991
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC).
Morita S; Baba H; Tsuburaya A; Takiuchi H; Matsui T; Maehara Y; Sakamoto J
Jpn J Clin Oncol; 2007 Jun; 37(6):469-72. PubMed ID: 17584825
[TBL] [Abstract][Full Text] [Related]
18. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
Cunningham D; Coleman R
Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
[TBL] [Abstract][Full Text] [Related]
19. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
Kobayashi A; Yamaguchi M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
[TBL] [Abstract][Full Text] [Related]
20. [5 -fluoropyrimidines for treatment of biliary tract cancers].
Morizane C; Okusaka T; Ueno H; Ikeda M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():529-33. PubMed ID: 16457319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
